Antisense oligonucleotides and the rational design of new antitumor drugs.
Prieto
J
J
Hernández-Alcoceba
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000235:genetics / Q000628:therapy; D011905:Genes, ras / Q000235:genetics; D015316:Genetic Therapy; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D010641:Phenotype; D019098:Telomerase / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense; D019098:Telomerase